Colorectal Neoplasms: all 5,738 studies

Page 21 of 58. Open to participants first (1,483), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) StatusCompletedNCT00912743Phase 2Results posted
• PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyCompletedNCT00911170Phase 3Results posted
• BIBF 1120 Versus Bevacizumab in Metastatic Colorectal CancerCompletedNCT00904839Phase 2Results posted
• Study to Evaluate Mechanisms of Acquired Resistance to PanitumumabCompletedNCT00891930Phase 2Results posted
• New Individualized Therapy Trial for Metastatic Colorectal CancerCompletedNCT00867334Phase 1/2Results posted
• Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) SubjectsCompletedNCT00865709Phase 2Results posted
• A Study of IMC-1121B (Ramucirumab) in Colorectal CancerCompletedNCT00862784Phase 2Results posted
• Outreach for Patients That Are Newly Eligible for Colorectal Cancer ScreeningTerminatedNCT00860249Not applicableResults posted
• NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal CancerCompletedNCT00856375Phase 2Results posted
• Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal CancerCompletedNCT00851084Phase 2Results posted
• Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal CancerCompletedNCT00842257Phase 2Results posted
• Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerTerminatedNCT00838578Phase 1/2Results posted
• Study of IMC-11F8 in Participants With Colorectal CancerCompletedNCT00835185Phase 2Results posted
• Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal CancerCompletedNCT00828984Phase 2Results posted
• Phase II Study of TAS-109 to Treat Advanced Colorectal CancerTerminatedNCT00824161Phase 2Results posted
• PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) TumorsCompletedNCT00819780Phase 2Results posted
• Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon CancerCompletedNCT00819208Not applicableResults posted
• Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal CancerTerminatedNCT00816777Phase 1/2Results posted
• Evaluating a Preference-based Intervention for Increasing Colorectal Cancer ScreeningCompletedNCT00810771Not applicableResults posted
• A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the LiverCompletedNCT00803647Phase 2Results posted
• Outreach for Patients With Uncompleted Colorectal Cancer Screening OrdersCompletedNCT00793455Not applicableResults posted
• Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)CompletedNCT00788957Phase 1/2Results posted
• Study of Gamma Interfereon in Metastatic Colorectal CarcinomaCompletedNCT00786643Phase 2Results posted
• A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal CancerTerminatedNCT00779311Phase 1Results posted
• Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study)CompletedNCT00778830Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.CompletedNCT00778102Phase 2Results posted
• Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal AdenomaCompletedNCT00773097Phase 2Results posted
• Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)CompletedNCT00770991Phase 1Results posted
• Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal CancerTerminatedNCT00766142Phase 2Results posted
• Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving IrinotecanCompletedNCT00748215Phase 2Results posted
• A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal CancerCompletedNCT00730158Phase 2Results posted
• Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving OxaliplatinCompletedNCT00729677Results posted
• FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal CancerCompletedNCT00724503Not applicableResults posted
• A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal CancerCompletedNCT00700570Phase 2Results posted
• A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.CompletedNCT00700102Phase 3Results posted
• Interventions to Improve Colorectal Cancer ScreeningCompletedNCT00692211Not applicableResults posted
• Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal CancerTerminatedNCT00677924Phase 1/2Results posted
• Study Of Sunitinib With FOLFIRI In Colorectal CancerCompletedNCT00668863Phase 2Results posted
• Efficacy of the Third Eye Retroscope Auxiliary Imaging SystemCompletedNCT00657371Not applicableResults posted
• Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00655499Phase 2Results posted
• Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)TerminatedNCT00642746Phase 2Results posted
• A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerTerminatedNCT00642603Phase 2Results posted
• Curcumin in Treating Patients With Familial Adenomatous PolyposisCompletedNCT00641147Phase 2Results posted
• A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal CancerCompletedNCT00636610Phase 2Results posted
• Study Of Sunitinib In Combination With Folfox In Patients With Colorectal CancerCompletedNCT00631410Phase 1Results posted
• Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyCompletedNCT00630786Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal CancerCompletedNCT00623805Phase 3Results posted
• A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line RegimenCompletedNCT00615056Phase 2Results posted
• Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)CompletedNCT00614393Phase 2Results posted
• Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon CancerCompletedNCT00612586Phase 2Results posted
• Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal CancerTerminatedNCT00609622Phase 2Results posted
• Fast-track Rehabilitation After Elective Colorectal and Small Bowel ResectionCompletedNCT00606944Not applicableResults posted
• A Study of Amifostine (Ethyol) in Patients With Colorectal CancerTerminatedNCT00601198Phase 2Results posted
• Study Of Sunitinib Plus FOLFOX In Patients With Solid TumorsCompletedNCT00599924Phase 1Results posted
• NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)CompletedNCT00598975Phase 2Results posted
• Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and BevacizumabTerminatedNCT00588900Phase 2Results posted
• Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)TerminatedNCT00585312Phase 3Results posted
• Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With CelecoxibCompletedNCT00582660Phase 2Results posted
• Trial of Aspirin and Arginine Restriction in Colorectal CancerCompletedNCT00578721Phase 2Results posted
• Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer PatientsCompletedNCT00574353Not applicableResults posted
• Effect of Panitumumab on the Pharmacokinetics of IrinotecanCompletedNCT00563316Phase 1Results posted
• Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based RegimenCompletedNCT00561470Phase 3Results posted
• Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer TreatmentsCompletedNCT00560560Phase 2Results posted
• Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal SurgeryCompletedNCT00559013Not applicableResults posted
• A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)CompletedNCT00551213Phase 2Results posted
• Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal CarcinomaCompletedNCT00545545Phase 1/2Results posted
• Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan TreatmentTerminatedNCT00538291Phase 2Results posted
• Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver InvolvementTerminatedNCT00537823Phase 2Results posted
• Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal CancerCompletedNCT00536809Phase 1Results posted
• TheraSphere for the Treatment of Liver MetastasesCompletedNCT00511862Phase 2Results posted
• Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPACompletedNCT00510692Phase 2/3Results posted
• Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal CancerCompletedNCT00508404Phase 2Results posted
• Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR TherapyCompletedNCT00503685Phase 2Results posted
• A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal CancerCompletedNCT00500292Phase 2Results posted
• A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOXCompletedNCT00494221Phase 1/2Results posted
• A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal CancerCompletedNCT00484939Phase 3Results posted
• Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT00467142Phase 2Results posted
• Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT00466505Phase 2Results posted
• Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal CancerCompletedNCT00460603Phase 1/2Results posted
• Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal CancerCompletedNCT00457691Phase 3Results posted
• A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in PatientsCompletedNCT00454116Phase 2Results posted
• Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal CancerCompletedNCT00450424Not applicableResults posted
• Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal CancerTerminatedNCT00449163Phase 2Results posted
• Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal CancerCompletedNCT00444678Phase 2Results posted
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesCompletedNCT00441337Phase 1Results posted
• Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver MetastasesCompletedNCT00440310Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.CompletedNCT00439517Phase 2Results posted
• A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal CancerCompletedNCT00437268Phase 2Results posted
• Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)TerminatedNCT00423150Phase 2Results posted
• Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and ChemotherapyCompletedNCT00419159Phase 2Results posted
• SPIRITT - Second-Line Panitumumab Irinotecan Treatment TrialCompletedNCT00418938Phase 2Results posted
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00416494Phase 2Results posted
• Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to TreatmentCompletedNCT00411450Phase 2Results posted
• Safety Study of PLX4032 in Patients With Solid TumorsCompletedNCT00405587Phase 1Results posted
• Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00399035Phase 3Results posted
• Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous TherapyTerminatedNCT00390364Phase 2Results posted
• First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOXCompletedNCT00384176Phase 2/3Results posted
• Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOXCompletedNCT00381862Phase 2Results posted
• A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.CompletedNCT00378482Phase 2Results posted
• PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine EfficacyCompletedNCT00364013Phase 3Results posted

← Colorectal Neoplasms overview